Identification and Validation of Novel Serum Autoantibodies Biomarkers for Staging Liver Fibrosis in Patients With Chronic Hepatitis B

Aim: Liver fibrosis monitoring is essential in patients with chronic hepatitis B (CHB). However, less robust, noninvasive diagnostic methods for staging liver fibrosis, other than liver biopsy, are available. Our previous study demonstrated a panel of cellular proteins recognized by autoantibodies t...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Saiping, Li, Jing, He, Xiaomin, Zhou, Jialing, Chen, Zhibin, Li, Xiaojin, Zhang, Bei, Ma, Hong, You, Hong, Huang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764302/
https://www.ncbi.nlm.nih.gov/pubmed/35059422
http://dx.doi.org/10.3389/fmed.2021.807087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764302/
https://www.ncbi.nlm.nih.gov/pubmed/35059422
http://dx.doi.org/10.3389/fmed.2021.807087

Ejemplares similares